Sumner Michael John has filed 33 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 4292 shares of INOVIO PHARMACEUTICALS, INC. ($INO) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 4292 | $0.00 | 0.0000 | 53,571,675 | 100.00% | 0.01% |
| March 31, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | F | Common Stock | 1223 | $1.74 | 33,576.0000 | 53,571,675 | 3.51% | 0.00% |
| March 31, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 4292 | $0.00 | 34,799.0000 | 53,571,675 | 14.07% | 0.01% |
| March 4, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Restricted Stock Unit | 29608 | $0.00 | 29,608.0000 | 53,571,675 | 9999.99% | 0.06% |
| March 4, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Common Stock Option | 36832 | $0.00 | 36,832.0000 | 53,571,675 | 9999.99% | 0.07% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | F | Common Stock | 3903 | $1.79 | 30,507.0000 | 53,571,675 | 11.34% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 5010 | $0.00 | 22,860.0000 | 53,571,675 | 28.07% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 11550 | $0.00 | 23,100.0000 | 53,571,675 | 33.33% | 0.02% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 5010 | $0.00 | 5,009.0000 | 53,571,675 | 50.00% | 0.01% |
| Feb. 26, 2026 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 11550 | $0.00 | 34,410.0000 | 53,571,675 | 50.52% | 0.02% |
| June 30, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 2916 | $0.00 | 17,850.0000 | 36,667,221 | 19.53% | 0.01% |
| June 30, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 2916 | $0.00 | 0.0000 | 36,667,221 | 100.00% | 0.01% |
| May 20, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Restricted Stock Unit | 28350 | $0.00 | 28,350.0000 | 36,667,221 | 9999.99% | 0.08% |
| May 20, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Common Stock Option | 35100 | $0.00 | 35,100.0000 | 36,667,221 | 9999.99% | 0.10% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 2385 | $0.00 | 2,385.0000 | 36,667,221 | 50.00% | 0.01% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 2385 | $0.00 | 15,614.0000 | 36,667,221 | 18.03% | 0.01% |
| May 15, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | F | Common Stock | 680 | $1.95 | 14,934.0000 | 36,667,221 | 4.36% | 0.00% |
| Feb. 27, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Common Stock Option | 42900 | $0.00 | 42,900.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 5010 | $0.00 | 13,229.0000 | 0 | 60.96% | 0.00% |
| Feb. 26, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 5010 | $0.00 | 10,019.0000 | 0 | 33.34% | 0.00% |
| Feb. 27, 2025 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Restricted Stock Unit | 34650 | $0.00 | 34,650.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Restricted Stock Unit | 4292 | $0.00 | 4,292.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Common Stock Option | 5708 | $0.00 | 5,708.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 2917 | $0.00 | 2,916.0000 | 0 | 50.01% | 0.00% |
| June 30, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 2917 | $0.00 | 8,219.0000 | 0 | 55.02% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 2386 | $0.00 | 5,302.0000 | 0 | 81.82% | 0.00% |
| May 15, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 2386 | $0.00 | 4,770.0000 | 0 | 33.34% | 0.00% |
| Feb. 28, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Common Stock Option | 18750 | $0.00 | 18,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Restricted Stock Unit | 15029 | $0.00 | 15,029.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Common Stock | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | M | Restricted Stock Unit | 35000 | $0.00 | 70,000.0000 | 0 | 33.33% | 0.00% |
| May 15, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Restricted Stock Unit | 85878 | $0.00 | 85,878.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | INOVIO PHARMACEUTICALS, INC. | $INO | Sumner Michael John | Chief Medical Officer | A | Common Stock Option | 112500 | $0.00 | 112,500.0000 | 0 | 9999.99% | 0.00% |